Frank Bepperling

A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery

R Huet, A.W. Siemons, Daniela Baus et al. · Canadian Journal of Anesthesia/Journal canadien d anesthésie · 2000 · 195 citations · Full text

Cardiac Surgery, Cardiac Anaesthesia, Surgery +5

The Pharmacokinetics and Tolerability of an Intravenous Infusion of the New Hydroxyethyl Starch 130/0.4 (6%, 500 mL) in Mild-to-Severe Renal Impairment

Cornelius Jungheinrich, Roland Scharpf, Manfred Wargenau et al. · Anesthesia & Analgesia · 2002 · 149 citations

The Pharmacokinetics and Tolerability of an Intravenous Infusion of the New Hydroxyethyl Starch 130/0.4 (6%, 500 mL) in Mild-to-Severe Renal Impairment

Cornelius Jungheinrich, Roland Scharpf, Manfred Wargenau et al. · Anesthesia & Analgesia · 2002 · 130 citations

Intravenous Infusion, Glomerulonephritis, Renal Function +18

Volume Efficacy and Reduced Influence on Measures of Coagulation Using Hydroxyethyl Starch 130/0.4 (6%) with an Optimised in???Vivo???Molecular Weight in Orthopaedic Surgery

Cornelius Jungheinrich, W Sauermann, Frank Bepperling et al. · Drugs in R&D · 2004 · 112 citations

Volume Efficacy, Vascular Surgery, Orthopaedics +7

Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4)] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers

J. Waitzinger, Frank Bepperling, G nther Pabst et al. · Clinical Drug Investigation · 1998 · 108 citations

Single-dose Infusion, New Hydroxyethyl Starch, Medicine +3